These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3830)

  • 1. Critique of single amine theories: evidence of a cholinergic influence in the major mental illnesses.
    Davis JM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():333-46. PubMed ID: 3830
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
    Goodwin FK; Post RM
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():299-332. PubMed ID: 769117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amines in mental disorders (author's transl)].
    Takahashi R
    Tanpakushitsu Kakusan Koso; 1977; 22(6):815-21. PubMed ID: 337391
    [No Abstract]   [Full Text] [Related]  

  • 4. Parasympathetic suppression of manic symptoms by physostigmine.
    Janowsky DS; el-Yousef K; Davis JM; Sekerke HJ
    Arch Gen Psychiatry; 1973 Apr; 28(4):542-7. PubMed ID: 4692153
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotransmitter-related enzymes in the major psychiatric disorders: I. Catechol-O-methyl transferase, monoamine oxidase in the affective disorders, and factors affecting some behaviorally correlated enzyme activities.
    Murphy DL; Wyatt RJ
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():277-88. PubMed ID: 769115
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders].
    Anokhina IP; Gamaleia NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Cholinergic and adrenergic balance in mania and schizophrenia.
    Davis JM; Janowsky D
    Psychopharmacol Bull; 1974 Jul; 10(3):49-50. PubMed ID: 4419332
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiovascular effects of neuroleptic and antidepressive drugs. Preliminary communication].
    Mohamedi S; Bathai H
    Med Welt; 1976 Jan; 27(4):168-71. PubMed ID: 2833
    [No Abstract]   [Full Text] [Related]  

  • 9. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1976 Oct; 18(22):89-96. PubMed ID: 10519
    [No Abstract]   [Full Text] [Related]  

  • 10. [Neurochemistry and clinical psychiatry (author's transl)].
    Gross G
    Fortschr Neurol Psychiatr; 1981 Jan; 49(1):34-42. PubMed ID: 6971791
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry and the schizophrenia. Old concepts and new hypothesis.
    Berger PA
    J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward hypotheses for a biochemical component in the vulnerability to schizophrenia.
    Kety SS
    Semin Psychiatry; 1972 Aug; 4(3):233-8. PubMed ID: 4155537
    [No Abstract]   [Full Text] [Related]  

  • 14. Biochemical aspects of schizophrenia.
    Lewis ME
    Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction: an overview of the issues surrounding the recognition and management of bipolar disorder and comorbid anxiety.
    Hirschfeld RM
    J Clin Psychiatry; 2006; 67 Suppl 1():3-4. PubMed ID: 16426109
    [No Abstract]   [Full Text] [Related]  

  • 16. [Findings of biochemical research on schizophrenia (author's transl)].
    Ackenheil M; Hippius H; Matussek N
    Nervenarzt; 1978 Nov; 49(11):634-49. PubMed ID: 31575
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value of brain imaging in assessment of cognitive symptoms. Cognitive and emotional impact of antipsychotic drug treatment]].
    Martinot JL; Peretti CS
    Encephale; 2006 Jan; 32 Pt 2():S3-5. PubMed ID: 16800076
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurotransmitter-related enzymes in the major psychiatric disorders: II. MAO and DBH in schizophrenia.
    Wyatt RJ; Murphy DL
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():289-97. PubMed ID: 769116
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.
    Uezato A; Meador-Woodruff JH; McCullumsmith RE
    Bipolar Disord; 2009 Nov; 11(7):711-25. PubMed ID: 19839996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.